Brief: India's Suven Life Sciences gets product patents in Hong Kong,India & U.S.
16/11/2017 05:05
Nov 16 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* Secures product patents in Hong Kong, India and USA
* Patents corresponds to new chemical entities for treatment
of
disorders associated with neurodegenerative diseases
Source text - http://bit.ly/2hCMQvM
Further company coverage: SUVP.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Patient Enrollment In Global Phase-3 Masupirdine Study
India's Suven Life Sciences gains after Masupirdine Phase-3 study completes patient enrollment
Brief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant